Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

  • There is currently no data for MXCT

TR-1

18 Aug 2023 17:25

RNS Number : 8348J
MaxCyte, Inc.
18 August 2023
 

TR-1: Notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

MAXCYTE INC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

17/08/2023

6. Date on which issuer notified (DD/MM/YYYY):

18/08/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

7.01%

0.23%

7.24%

7,501,002

Position of previous notification (if

applicable)

6.84%

0.39%

7.24%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

US57777K1060

7,262,884

7.01%

SUBTOTAL 8. A

7,262,884

7.01%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

N/A

N/A

238,118

0.23%

SUBTOTAL 8. B 1

238,118

0.23%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Investment Management (UK) Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Institutional Trust Company, National Association

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Fund Advisors

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Canada Holdings LP

BlackRock Canada Holdings ULC

BlackRock Asset Management Canada Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Capital Holdings, Inc.

BlackRock Advisors, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Advisors (UK) Limited

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

Amethyst Intermediate, LLC

Aperio Holdings, LLC

Aperio Group, LLC

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

BlackRock Regulatory Threshold Reporting Team Jana Blumenstein

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

18 August 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLZZGMRVRDGFZM
Date   Source Headline
21st Jan 20259:13 amRNSHolding(s) in Company
17th Jan 20251:15 pmRNSHolding(s) in Company
15th Jan 20254:00 pmRNSHolding(s) in Company
13th Jan 20258:05 amRNSPreliminary Fourth Quarter and Full Year Results
2nd Jan 20255:53 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSExercise of options and PDMR dealing
23rd Dec 20247:00 amRNSMaxCyte Announces Retirement of Board Member
19th Dec 20244:26 pmRNSHolding(s) in Company
18th Dec 20243:31 pmRNSHolding(s) in Company
10th Dec 20245:16 pmRNSHolding(s) in Company
10th Dec 20245:12 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSMaxCyte Streamlines Operations and Raises Guidance
2nd Dec 20245:09 pmRNSTotal Voting Rights and Block Listing Return
28th Nov 20243:05 pmRNSHolding(s) in Company
28th Nov 20243:05 pmRNSHolding(s) in Company
19th Nov 20249:49 amRNSHolding(s) in Company
7th Nov 20247:00 amRNSFiling of 10Q form
7th Nov 20247:00 amRNSThird Quarter 2024 Financial Results
6th Nov 20241:43 pmRNSExercise of options and PDMR dealing
4th Nov 20241:23 pmRNSTotal Voting Rights
31st Oct 20247:00 amRNSExercise of options and PDMR dealing
18th Oct 20249:24 amRNSGrant of Options and Restricted Stock Units
15th Oct 20241:05 pmRNSMaxCyte Appoints Cynthia Collins to Board
11th Oct 20241:00 pmRNSNotice of Results
10th Oct 20241:05 pmRNSMaxCyte Appoints Ali Soleymannezhad as CCO
3rd Oct 20249:41 amRNSExercise of options and PDMR dealing
1st Oct 20249:47 amRNSExercise of options and PDMR dealing
1st Oct 20247:00 amRNSTotal Voting Rights
27th Sep 20244:15 pmRNSHolding(s) in Company
27th Sep 20243:29 pmRNSHolding(s) in Company
20th Sep 20245:02 pmRNSHolding(s) in Company
16th Sep 20247:00 amRNSTR-1: Notification of major holdings
16th Sep 20247:00 amRNSSigning of Strategic Platform License
6th Sep 20245:07 pmRNSExercise of options and PDMR dealing
3rd Sep 20243:38 pmRNSTotal Voting Rights
29th Aug 202410:06 amRNSExercise of options and PDMR dealing
7th Aug 20247:05 amRNSFiling of Form 10-Q
7th Aug 20247:00 amRNSSecond Quarter and Half-Year Results
1st Aug 20244:31 pmRNSTotal Voting Rights
31st Jul 20247:00 amRNSExercise of options and PDMR dealing
10th Jul 20249:15 amRNSNotice of Results
9th Jul 20249:14 amRNSChange of Name of Nominated Adviser and Broker
3rd Jul 20247:00 amRNSTR-1: Notification of major holdings
2nd Jul 202411:18 amRNSExercise of options and PDMR dealing
2nd Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20242:34 pmRNSPublication of Annual Report
14th Jun 20247:00 amRNSGrant of Options and Restricted Stock Units
12th Jun 20247:00 amRNSResult of AGM
11th Jun 20247:00 amRNSPDMR Dealing
3rd Jun 20243:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.